Brain's immune system triggers frontotemporal dementia

by Nicholas Weiler,University of California, San FranciscoFrontotemporal dementia (FTD), the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells

Updated on: February 28,2024

Brain's immune system triggers frontotemporal dementia

by Nicholas Weiler,University of California, San FranciscoFrontotemporal dementia (FTD), the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells

Updated on:February 28,2024

Brain's 'speedometer' could help solve part of dementia puzzle

by University of ExeterCredit: Unsplash/CC0 Public DomainNearly one million people in the UK have dementia. People living with the most common form, Alzheimer's disease, can experience diffic

Updated on: May 18,2024

Brain's 'speedometer' could help solve part of dementia puzzle

by University of ExeterCredit: Unsplash/CC0 Public DomainNearly one million people in the UK have dementia. People living with the most common form, Alzheimer's disease, can experience diffic

Updated on:May 18,2024

New research offers hope for treating inherited peripheral neuropathies

by Uniformed Services University of the Health Sciences (USU)Treating S63del mice for 21 days with tadalafil or CYR119 restores myelin thickness and nerve conduction in sciatic nerves. Credit:Ce

Updated on: November 14,2024

New research offers hope for treating inherited peripheral neuropathies

by Uniformed Services University of the Health Sciences (USU)Treating S63del mice for 21 days with tadalafil or CYR119 restores myelin thickness and nerve conduction in sciatic nerves. Credit:Ce

Updated on:November 14,2024

rTMS as a treatment for Veterans with cognitive impairment and multiple co-morbidities

by IOS PressSchematic of a typical rTMS setup. Credit: Dr. ChengCurrent treatments for Alzheimer's disease are of limited effectiveness and do not halt the progression of the disease and asso

Updated on: March 09,2024

rTMS as a treatment for Veterans with cognitive impairment and multiple co-morbidities

by IOS PressSchematic of a typical rTMS setup. Credit: Dr. ChengCurrent treatments for Alzheimer's disease are of limited effectiveness and do not halt the progression of the disease and asso

Updated on:March 09,2024

Worsening heat waves pose unique risks to people living with neurodegenerative disease

byUniversity of California, Los AngelesCredit: neerja panchal from PexelsAs 2024 is set to end as Earth's hottest year on record—breaking the previous record set in 2023– a UCLA Health resea

Updated on: February 05,2025

Worsening heat waves pose unique risks to people living with neurodegenerative disease

byUniversity of California, Los AngelesCredit: neerja panchal from PexelsAs 2024 is set to end as Earth's hottest year on record—breaking the previous record set in 2023– a UCLA Health resea

Updated on:February 05,2025

FAU site for first US clinical trial for Lewy Body dementia

by Florida Atlantic UniversityThe South Florida clinical trial is directed by one of the world's leading neuroscientists and an expert on LBD, James E. Galvin, M.D., M.P.H., a professor of cl

Updated on: February 28,2024

FAU site for first US clinical trial for Lewy Body dementia

by Florida Atlantic UniversityThe South Florida clinical trial is directed by one of the world's leading neuroscientists and an expert on LBD, James E. Galvin, M.D., M.P.H., a professor of cl

Updated on:February 28,2024

Nutritional drink can help to conserve memory in case of prodromal Alzheimer's disease

by Saarland UniversityProfessor Tobias Hartmann, Saarland University. Credit: Saarland UniversityThe study did not find a significant benefit in broad cognitive function (the study primary endpoi

Updated on: February 28,2024

Nutritional drink can help to conserve memory in case of prodromal Alzheimer's disease

by Saarland UniversityProfessor Tobias Hartmann, Saarland University. Credit: Saarland UniversityThe study did not find a significant benefit in broad cognitive function (the study primary endpoi

Updated on:February 28,2024

Flotillin is a novel diagnostic blood marker of Alzheimer's disease

by Nagoya City UniversityFlotillin in serum collected from patients with AD and non-AD cases was examined by western blot analysis. Intensity of flotillin bands was quantified using Image J. A, The re

Updated on: March 30,2024

Flotillin is a novel diagnostic blood marker of Alzheimer's disease

by Nagoya City UniversityFlotillin in serum collected from patients with AD and non-AD cases was examined by western blot analysis. Intensity of flotillin bands was quantified using Image J. A, The re

Updated on:March 30,2024

Overcoming nicotine withdrawal: Clues found in neural mechanisms of the brain

Updated on: March 08,2025

Overcoming nicotine withdrawal: Clues found in neural mechanisms of the brain

Updated on:March 08,2025

Link between gum disease and cognitive decline in Alzheimer's

by King's College LondonDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A new study jointly led by King's College London and the University

Updated on: February 28,2024

Link between gum disease and cognitive decline in Alzheimer's

by King's College LondonDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A new study jointly led by King's College London and the University

Updated on:February 28,2024

How dementia quality registries can contribute to better dementia care

by Austrian Institute for Health Technology Assessment GmbHCredit: Pixabay/CC0 Public DomainThe Austrian Institute for Health Technology Assessment (AIHTA) has investigated which key factors are essen

Updated on: May 11,2024

How dementia quality registries can contribute to better dementia care

by Austrian Institute for Health Technology Assessment GmbHCredit: Pixabay/CC0 Public DomainThe Austrian Institute for Health Technology Assessment (AIHTA) has investigated which key factors are essen

Updated on:May 11,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on: March 30,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on:March 30,2024